Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine

Upur, Halmurat; Yusup, Abdiryim; Baudrimont, Isabelle; Umar, Anwar; Berke, Benedicte; Yimit, Dilxat; Lapham, Jaya Conser; Creppy, Edmon E.; Moore, Nicholas

doi:https://doi.org/10.1093/ecam/nen062

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Methods Results Discussion Conclusions References Copyright Related Articles

Original Article | Open Access

Volume 2011 | Article ID 251424 | https://doi.org/10.1093/ecam/nen062

Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine

Halmurat Upur,¹Abdiryim Yusup,¹Isabelle Baudrimont,²Anwar Umar,¹Benedicte Berke,^1,2Dilxat Yimit,¹Jaya Conser Lapham,¹Edmon E. Creppy,³and Nicholas Moore^1,4

Received20 Jun 2008

Accepted11 Sept 2008

Published18 Jun 2011

Abstract

Abnormal Savda Munziq (ASMq) is a traditional Uighur medicinal herbal preparation, commonly used for the treatment and prevention of cancer. We tested the effects of ethanol extract of ASMq on cultured human hepatoma cells (HepG2) to explore the mechanism of its putative anticancer properties, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide, neutral red and lactate dehydrogenase (LDH) leakage assays, testing the incorporation of ³[H]-leucine and ³[H]-nucleosides into protein, DNA and RNA, and quantifying the formation of malondialdehyde-thiobarbituric acid (MDA) adducts. ASMq ethanol extract significantly inhibited the growth of HepG2 and cell viability, increased the leakage of LDH after 48 hours or 72 hours treatment, in a concentration- and time-dependent manner (P < .05). Cellular protein, DNA and RNA synthesis were inhibited in a concentration- and time-dependent manner (P < .05). No significant MDA release in culture medium and no lipid peroxidation in cells were observed. The results suggest that the cytotoxic effects of ASMq ethanol extract might be related to inhibition of cancer cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis.

1. Introduction

The therapeutic utilization of plants is part of universal human culture, and products derived from plants are frequently used for the treatment or prevention of diseases. Plants, vegetables, herbs and spices used in folk and traditional medicine are one of the sources of cancer drug discovery and development [1]. A major group of these products include pigments, vitamins, phenolic lactones, flavonoids, tannins and alkaloids [2, 3]. Although the mechanism underlying their anticancer effects is often still unclear, the fact that the consumption of fruits, vegetables and some traditional herbal preparations could lower the incidence of carcinogenesis at a wide variety of sites is broadly supported [4, 5]. The vinca alkaloids and taxane diterpenes are examples of successful plant-derived anticancer agents [6]. In the last few years, several other herbal products capable of anticancer effects have been identified, the anticancer properties of which are related to the regulation of cancer-related gene express, induction of apoptosis, cell cycle arrest and/or DNA fragmentation as well as inhibition of different cellular enzymes [7–11].

Traditional Uighur medicine, one of the main medical system in Central Asia, is based on four humors: fire, air, water and earth, which generate four body fluids: Kan (blood), Belghem (phlegm), Sapra (yellow bile) and Savda (black bile). Unbalanced body fluids will cause diseases, and traditional Uighur formulations will regulate the balance of body fluids and cure the disease [12]. Abnormal Savda Munziq (ASMq), a herbal formulation of traditional Uighur medicine, is widely used in the Xinjiang region of China, and especially for the treatment and prevention of cancer, diabetes, cardiovascular disorders as well as chronic asthma. Its anticancer properties are usually applied by Uighur physicians to the treatment and prevention of digestive cancers. For liver, stomach and colon cancers, the recommended dose is 500 mL three times a day. The putative mechanism of the anticancer effect is still unclear and needs further investigation. In a previous study, we found that ASMq aqueous extract had scavenging effects to various reactive oxygen species (ROS), and could protect against OH-induced mitochondrial and DNA oxidative damage in vitro [13–16].

In this article, we carried out experimental studies on ASMq ethanol extract on cultured HepG2 cells to elucidate the initial molecular mechanisms responsible for its anticancer effects.

2. Methods

2.1. Chemicals Reagents

Dulbecco's modified Eagle medium (DMEM), fetal calf serum (FCS), ethylene diamine tetra-acetic acid (EDTA), phosphate-buffered saline (PBS), N-lauroyl sarcosine (N-LS), ribonuclease A (RNase A), proteinase K, ethidium bromide, trypsine-0.02% EDTA mixture were from Sigma-Aldrich (Lyon, France). ³[H]-leucine, ³[H]-thymidine and ³[H]-uridine were from Perkin Elmer Life Sciences Inc. (Boston, MA, USA). All other chemicals used were of analytical grade.

2.2. Preparation of Ethanol Extract of ASMq

ASMq consists of powdered material of the 10 plants described in Table 1 [17]. The formulation is prepared according to a proprietary preparation [18]. A voucher of each plant is stored in the herbarium of Xinjiang Institute of Ecology and Geography, Chinese Academy of Science. Plant materials were purchased from Xinjiang Hospital of Traditional Uighur Medicine.

Powdered material (7.8 kg) was macerated in ethanol 95% [1 : 10 (w/v)] at room temperature for 4 hours with continuous stirring. The maceration was repeated three times (4 hours). After evaporation, the residue was extracted by petroleum ether. The remaining water fraction was concentrated to dryness under reduced pressure and low temperature on a rotary evaporator. Extract yield of plant material was 935 g (12%) (w/w). Extract was dissolved in distilled water (100 mg mL⁻¹) and kept at −20°C prior to utilization. The other concentrations used in the experiment were prepared by addition of cell culture medium (DMEM).

2.3. Cell Lines and Culture Medium

Human hepatoma adherent cell lines (HepG2) were obtained from the American Type Culture Collection (ATCC). Cells were cultured and maintained with DMEM supplemented with 10% FCS, 2% L-glutamine (200 mM) and 1% penicillin-streptomycin (100 U to 100 mg mL⁻¹) in a humidified 5% CO₂–95% air mixture at 37°C.

2.4. MTT Assay

Cell viability was determined using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Cells were seeded in 96-well microplates (5000 cells/well/200 mL) and routinely cultured in a humidified incubator for 24 hours. Cell culture mediums were removed with a pipette and herbal extracts were added in serial concentrations (ranging from 0.05 to 10 mg mL⁻¹) and re-incubated for 72 hours. We also tested a control group (DMEM without herbal extract), a blank group (without cells or medium). The medium with or without herbal extract was then discarded, and 100 mL of MTT solution (0.5 mg mL⁻¹ in DMEM) was added to every well and re-incubated for an additional 2 hours. One hundred microliters of 10% SDS, 0.01 M HCl solution was added to each well to dissolve the formazon crystals formed. The plates were then read on a microplate reader (DYNATECH MR 4000, France) at 560 nm. In this test, four wells were used for each concentration of ASMq, and five independent experiments were performed.

2.5. Neutral Red Uptake Assay

Cells were seeded in 96-well microplates (10 000 cells/well/200 mL), routinely cultured in a humidified incubator for 24 hours. Cells were maintained in culture and exposed to ASMq ethanol extract over a range of concentrations (0.5–7.5 mg mL⁻¹). After 48 hours exposure to ASMq, neutral red (NR) uptake test was performed according to the procedure described by Creppy [19]. Briefly, at the end of the treatment, the medium with or without ASMq was discarded and 200 L of freshly prepared neutral red solution (50 g mL⁻¹) was added to every well and re-incubated for an additional 4 hours at 37°C. Thereafter, the cells were carefully washed twice with 200 L of PBS to eliminate extracellular NR. The incorporated dye was eluted from the cells by adding 200 L elution medium (50% ethanol supplemented with 1% acetic acid, v/v) into each well followed by gentle shaking of microplate for 15 min. The plates were then read at 540 nm using a microplate reader (DYNATECH MR 4000, France). The number of cells in the presence of ASMq was compared to that observed in control cultures and the percentage of viable cells calculated. The IC₅₀ is determined and expressed as microgram per milliliter.

2.6. Lactate Dehydrogenase Leakage Assay

HepG2 cells (1 × 10⁵ cells mL⁻¹well⁻¹) were pre-incubated in 24-well multidishes for 24 hours at 5% CO₂–95% air 37°C. Cell viability was assessed by lactate dehydrogenase (LDH) leakage trough the membrane into the medium. Aliquots of the cell culture supernatants from control and serial concentration of ASMq ethanol extract treated cultures were tested after 48 or 72 hours incubation for the presence of LDH using a LDH assay kit (Biomerieux, France). In this test, three wells were used for each concentration of ASMq, and three independent experiments were performed.

2.7. Cellular Protein, DNA and RNA Synthesis Assay

HepG2 cells (2.5 × 10⁵ cells/mL/well) were cultured in 24-well multidishes for 48 hours at 37°C. Five concentrations ranging from 0.5 to 7.5 mg mL⁻¹ of extract were used. The control cultures were prepared by adding DMEM without any addition. Four wells were used for each concentration, and two independent experiments were performed. After 24 or 48 hours incubation at 37°C with or without extract, the medium removed and 2 mCi mL⁻¹ of a radioactive protein synthesis precursor, ³[H]-leucine (specific activity, 185 GBq mmol⁻¹) or 2 mCi mL⁻¹ of radioactive DNA synthesis precursor, ³[H]-thymidine (specific activity, 3259.76 GBq mmol⁻¹) or 2 mCi mL⁻¹ of radioactive RNA synthesis precursor, ³[H]-uridine (specific activity, 888 GBq mmol⁻¹) was incorporated during a 2.5 hours pulse. Once the pulse was finished, the medium was removed and cells were harvested by trypsinization. After centrifuged at 600 g for 5 min at 10°C, the supernatants were removed and cell pellets were resuspended by adding 300 mL of 20% NaOH and sonicated for 30 s with Bioblock sonicater at 75 mV, and all the samples were incubated for 20 min at 37°C. Twenty microliters of each homogenate was taken for total protein quantification using the Bradford method [20]. The samples were kept in −20°C freezer after addition of 1 mL of cold TCA (40%) until filtration. Lastly, the samples were filtered on 3 mm Whatman microfiber filter discs, which were dried at 80°C for 20 min. The radioactivity on the paper filters was counted with liquid scintillation analyzer after addition of 5 mL of Beckman Ready Organic supplemented by 0.9% acetic acid. The c.p.m. values were adjusted with total protein content in each sample. In this test, four wells were used for each concentration of ASMq ethanol extract, and three independent experiments were performed.

2.8. Extraction and Determination of Malondialdehyde-Thiobarbituric Acid Adduct

HepG2 (1 × 10⁵ cells/well/mL) were cultured in 24-well multidishes for 24 hours at 37°C. Five concentrations ranging from 0.5 to 7.5 mg mL⁻¹ of ASMq were used. The control cultures were prepared by adding DMEM without any addition. After incubation with or without extract, the culture medium was removed. After rinsing with 0.5 mL of fresh-cold PBS twice, cells were collected by trypsinization, centrifuged at 600 g for 5 min. The cell pellets were resuspended in 270 μL of STE (0.1 M NaCl, 20 mM EDTA, 50 mM Tris–HCl, pH 8.0), after adding 25 L of 7% SDS the cells were sonicated for 30s at 75 mV, 20 mL of each homogenate was taken for total protein quantification [20]. The cells were lysed with 20 L of SDS 7% (w/v), 300 L of 0.1 M HCl, 40 L of phosphotungstic acid 1% (w/v) and 300 L of 0.67% (w/v) thiobarbituric acid. The tubes were shaken for 1 min and incubated at 80°C for 1 hour in the dark. They were further placed for 20 min in an ice bath (0°C). After this period, 300 μL of n-butanol was added and tubes were shaken vigorously for 1 min. After centrifugation for 10 min at 900 g at 4°C, the n-butanol phase from each sample containing MDA-TBA adduct was separated and analyzed by high performance liquid chromatography (HPLC) with fluorometric detection [21].

The HPLC system consisted of a chromatography pump (Bischoff Chromatography, Germany) equipped with a Shimadzu 8450 Fluorescence HPLC Monitor (Japan Spectroscopic Co.). Analysis of the malondialdehyde-thiobarbituric (MDA-TBA) adducts was performed at room temperature on a Ultrasep C18 column using methanol–water 40 : 60 (v/v) as the mobile phase adjusted to pH 8.3 by addition of 1 M KOH. The flow rate was maintained at 0.5 mL/min. The excitation and emission wavelengths were 515 and 553 nm, respectively. The amount of MDA-TBA measured was referred to the protein content of cellular homogenates using the Bradford method [20]. In this test, three wells were used for each concentration of ASMq, and two independent experiments were performed. Pic3 software was used for the analysis of chromatography.

2.9. Statistical Analysis

The data are expressed as mean ± SD of at least three independent determinations in triplicate or quadruplicate for each experimental point. The statistical differences between treated groups and control groups were determined by Student's t-test, and the significance threshold was set to P < .05.

3. Results

3.1. Inhibition of HepG2 Cell Growth by ASMq Ethanol Extract

After 72 hours incubation, ASMq ethanol extract inhibited HepG2 cell growth in a concentration-dependent manner (Figure 1). ASMq ethanol extract reached its maximum inhibitory effect (68.4%) at 2.5 mg mL⁻¹ (Figure 1). The IC₅₀ was determined to be 0.8 ± 0.12 mg mL⁻¹.

3.2. Inhibition of HepG2 Cell Viability by ASMq Ethanol Extract

ASMq ethanol extract significantly inhibited HepG2 cell viability in a concentration-dependent manner after 48 hours incubation. IC₅₀ was 0.9 ± 0.2 mg mL⁻¹ (Figure 2).

3.3. Increase of LDH Leakage by ASMq Ethanol Extract

There was a significant increase of HepG2 cell membrane LDH leakage after incubation with serial concentrations of ASMq ethanol extract (Figure 3). In agreement with the results of the MTT test and neutral red test, significant toxicity was observed in HepG2 cells with ASMq concentrations from 0.5 to 7.5 mg mL⁻¹ after 48 or 72 hours of treatment (P < .05). Concentration dependence was observed at both 48 hours and 72 hours incubation. In addition, ASMq ethanol extract showed a time-dependent toxicity in our experimental condition with effects greater at 72 hours than at 48 hours (Figure 3).

3.4. Inhibition of Cellular Synthesis of Protein, DNA and RNA by ASMq Ethanol Extract

There was a concentration-dependent inhibition of protein synthesis after 24 hours incubation. After 48 hours, the inhibition no longer was dose-dependent over the range of doses tested, but seemed stable around 43–52%. Inhibition was significantly greater at 48 than at 24 hours for all concentrations (P < .05) (Figure 4).

Increasing concentrations of ASMq ethanol extract from 0.5 to 7.5 mg/mL dose-dependently inhibited cellular DNA synthesis from 8.3 to 35.4% at 24 hours, from 15.5% to 48.5% at 48 hours (Figure 5). Inhibition was greater after 48 hours than after 24 hours incubation.

Synthesis of RNA in HepG2 cells was inhibited in a concentration-dependent manner from 14.7% to 46.4% and 26.0% to 55.7% at 24 hours and 48 hours, respectively (Figure 6). There was no clear time-dependent increase in this inhibition.

3.5. Lipid Peroxidation of HepG2 Cells by ASMq Ethanol Extract

There was no significant MDA release in culture medium and no lipid peroxidation compared to controls, even at the highest concentration (10, 20 or 50 mg mL⁻¹) (data not shown). This result is in accordance with a previous study showing ASMq had scavenging effects on reactive oxygen species [14].

4. Discussion

ASMq, used for the treatment and prevention of cancers, is made from several plants (Table 1). Pharmacological information that can be related to cancer inhibiting effects of some of the plants is outlined in Table 2.

Various antioxidative activities involving detoxification such as superoxide anion radical scavenging, inhibition of hydrogen peroxide, enhancement of superoxide dismutase, catalase and glutathion peroxidase as well as iron-chelating activities have been reported for several plants extracts such as Anchusa italica, Foeniculum vulgare, Glycyrrhiza sp., Lavandula angustifolia and Melissa officinalis.

Anti-inflammatory activity has been demonstrated using chemical-induced writhing test and carrageenan paw edema for polyphenolic extract and essential oil of L. angustifolia [43]. It is thought that these antioxidant and anti-inflammatory properties are related to the treatment of cancer.

Findings on licorice have shown in vitro and in vivo anticancer effects [28, 50]. Glycyrrhetinic acid, constituent of G. glabra and G. uralensis, developed anti-initiating and anti-promoting activities [39]. Isoliquiritigenin, one of the flavonoids of G. glabra, induced apoptosis of MGC-803 cells through calcium and Deltapsi-dependent pathways [36] as well as cell cycle arrest and cell growth inhibition [32]. Isoliquiritigenin also activated macrophages and cytotoxicity of splenic lymphocytes [33]. Glabrene showed an estrogen receptor-dependent affinity higher than glabridin with growth-promoting effect at low concentration and ER-independent antiproliferative activity at concentrations above 15 mM [37]. Licochalcone-A, phytoestrogen from G. glabra, decreased the anti-apoptotic protein bcl-2 and modified the bcl2-/bax ratio in favor of apoptosis [38]. Beta-hydroxy-DHP from G. Glabra extract induced Bcl-2 phosphorylation, G2/M cell cycle arrest and apoptosis in breast and prostate tumor cells [34]. Recently, the ethanol extract of G. uralensis root has been shown to possess anticancer activity through upregulation of tumor suppressor gene p53, pro-apoptotic protein Bax and p21waf1/cip1 and downregulation of cdk 2 and cyclin E. The extract also caused G1 cell cycle arrest [31]. The antiangiogenic activity of G. glabra is also a potential supplemental source to eradicate tumor growth [28].

Other plants have shown interesting results that can suggest their potential uses as antitumoral agents. Essential oils from L. angustifolia showed strong antimutagenic activity in Salmonella typhimurium strains exposed to the direct mutagen 2-nitrofluorene [41]. Lavender oil and linalool have also been demonstrated to be cytotoxic to human skin cells in vitro [42]. Oil from M. officinalis induced cytotoxicity on human cancer lines (A549, MCF-7, Caco-2, HL-60, K562) and a mouse cell line B16F10 [49].

Though the herbal remedy tested here has been used extensively in traditional Uighur medicine, its effects on cancer cell growth or metabolism had not been tested previously.

In the present study, we used human hepatoma cells (HepG2) to examine the cytotoxic effects of ASMq ethanol extract to elucidate the initial molecular mechanisms responsible for these effects. We demonstrated that ASMq ethanol extract had significant cytotoxic effect by reducing the cell growth rate and cell viability, increasing the extra-cellular LDH leakage and inhibiting cellular protein, DNA and RNA synthesis.

Inhibiting cancer cell growth has been a continuous effort in cancer treatment. Most anticancer agents act by reducing cell growth and inducing cell death through more or less detailed and complicated pathways. Our results showed that ASMq ethanol extract inhibits HepG2 cell growth in a concentration-dependent manner after 72 hours incubation. Even at a low concentration, there still was a potent inhibitor effect, the 50% inhibition concentration being determined to be about 0.8 mg mL⁻¹ in our experimental conditions. This result was confirmed by the neutral red test showing that ASMq ethanol extract decreased HepG2 cell viability in a concentration-dependent manner after 48 hours incubation.

The most frequently used endpoints in cytotoxicity are the breakdown of the cellular permeability barrier, measured by dye exclusion (trypan blue) or by the release of intracellular enzymes like LDH as a consequence of membrane damage or cell detachment [51]. It is well known that cellular injury may lead to a complex sequence of changes to structural and molecular events, frequently culminating in cell death. Many subcellular structures, such as the plasma membrane, nucleus, mitochondria, endoplasmic reticulum and lysosomes are all targets for anticancer agents [52]. The LDH leakage assay is based on the principle that dead cells lose the ability to maintain their plasma membrane integrity, permitting intracellular constituents such as LDH to leak out of the cell into the culture medium. ASMq ethanol extract induced a significant increase in extra-cellular LDH levels at both 48 hours and 72 hours, in a concentration-dependent manner. ASMq ethanol extract also exhibited time-dependent properties on LDH leakage since the effects at 72 hours were greater than at 48 hours. ASMq ethanol extract may alter the integrity of HepG2 cell plasma membranes either directly or as a secondary result of damage to some other cell component and alter the net rates of nutrient uptake in the cells. Therefore, the cytotoxic effects of ASMq ethanol extract might at least in part be correlated with loss of cell plasma membrane integrity and potential.

Lipid peroxidation is one of the consequences of oxidative damage and has been suggested as a general mechanism for cell injury and death. MDA, the end product of lipid peroxidation, has been extensively studied and measured as an index of lipid peroxidation and as a marker of oxidative stress [53]. Many anticancer agents causing cell death are known to induce an overproduction of ROS, and thereby causing oxidative damage to DNA, proteins and lipids and possibly inducing apoptosis. But in our experimental conditions ASMq did not induce significant lipid peroxidation in HepG2 cells after 24 or 48 hours. This indicates that probably the mechanism leading to loss of cell membrane integrity is not due to ROS, but more probably to inhibition of lipoproteins in membrane since as shown above ASMq inhibited protein synthesis.

To explore its effect on cell mechanisms, the effects of ASMq ethanol extract on some basic cell functions such as protein, DNA and RNA synthesis were studied showing a concentration and time-dependent inhibition of DNA and protein synthesis in cells treated with ASMq ethanol extract as reflected by its inhibition of 3H-thymidine and 3H-leucine uptake. Our results showed that ASMq ethanol extract obviously decreased DNA and protein synthesis at 24 and 48 hours incubation. For DNA synthesis, the inhibition was concentration-dependent after 24 and 48 hours incubation, with also a time-dependent effect, the inhibition being greater at 48 than at 24 hours for all concentrations, whereas for protein synthesis the inhibition was maximal from the first concentration at 48 hours. We found dose dependence for RNA synthesis, but no clear time dependence: there was no difference in the inhibition after 24 or 48 hours incubation. DNA, RNA and protein synthesis are directly proportional to cellular growth rate [54, 55]. Our results likely support this viewpoint: the inhibition of cell growth by ASMq ethanol extract seems closely related to cellular DNA, RNA and protein synthesis inhibition. Thus, inhibition of cellular DNA, RNA and protein synthesis might be involved in the mechanisms of ASMq ethanol extract cytotoxicity effect.

5. Conclusions

HepG2 cell growth was concentration dependently inhibited by ASMq ethanol extract. Our findings suggest that the cytotoxic effect of ASMq ethanol extract is a combination of its effects in reduction of HepG2 cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis. As an herbal preparation, ASMq ethanol extract undoubtedly contains a variety of active compounds such as alkaloids, polyphenols or terpenoids, as well as vitamins and fatty acids, which may act on different pathways of cancer cell growth. Further studies will be needed to identify the active compound(s) that confer anticancer activities to ASMq ethanol extract. Once such compounds are identified, the mechanisms by which they exert their effects can begin to be characterized.

Funding

National Natural Science Foundation of China (30260128); State Administration of Traditional Chinese Medicine of China (2005LHR21).

References

F. I. Abdullaev and J. J. Espinosa-Aguirre, “Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials,” Cancer Detection and Prevention, vol. 28, no. 6, pp. 426–432, 2004.
View at: Publisher Site | Google Scholar
A. B. da Rocha, R. M. Lopes, and G. Schwartsmann, “Natural products in anticancer therapy,” Current Opinion in Pharmacology, vol. 1, no. 4, pp. 364–369, 2001.
View at: Publisher Site | Google Scholar
M. J. Balunas and A. D. Kinghorn, “Drug discovery from medicinal plants,” Life Sciences, vol. 78, no. 5, pp. 431–441, 2005.
View at: Publisher Site | Google Scholar
B. R. Cassileth, “Alternative and complementary cancer treatments,” Oncologist, vol. 1, no. 3, pp. 173–179, 1996.
View at: Google Scholar
P. A. de Smet, “Herbal remedies,” The New England Journal of Medicine, vol. 347, pp. 2046–2056, 2002.
View at: Publisher Site | Google Scholar
G. Pinn, “Herbal medicine in oncology,” Australian Family Physician, vol. 30, pp. 575–580, 2001.
View at: Google Scholar
S. M. Y. Lee, M. L. Y. Li, Y. C. Tse et al., “Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway,” Life Sciences, vol. 71, no. 19, pp. 2267–2277, 2002.
View at: Publisher Site | Google Scholar
X.-K. Li, M. Motwani, W. Tong, W. Bornmann, and G. K. Schwartz, “Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells,” Molecular Pharmacology, vol. 58, no. 6, pp. 1287–1293, 2000.
View at: Google Scholar
A. K. Joe, H. Liu, M. Suzui, M. E. Vural, D. Xiao, and I. B. Weinstein, “Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines,” Clinical Cancer Research, vol. 8, no. 3, pp. 893–903, 2002.
View at: Google Scholar
J. Wu, Y. Wu, and B. B. Yang, “Anticancer activity of Hemsleya amabilis extract,” Life Sciences, vol. 71, no. 18, pp. 2161–2170, 2002.
View at: Google Scholar
S.-T. Huang, R.-C. Yang, L.-J. Yang, P.-N. Lee, and J.-H. S. Pang, “Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,” Life Sciences, vol. 72, no. 15, pp. 1705–1716, 2003.
View at: Publisher Site | Google Scholar
H. Upur, A. Yusup, A. Umar, and N. Moore, “Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda,” Therapie, vol. 59, pp. 483–484, 2004.
View at: Google Scholar
A. Abuduaini, A. Yusup, and H. Upur, “Studies on the protective effects of Munziq and Mushil of Abnormal Savda to OH-induced DNA damage,” Zhongyao Yaoli yu Linchuang Zazhi, vol. 16, pp. 34–36, 2000.
View at: Google Scholar
H. Upur and A. Yusup, “Antioxidative effects of Munziq and Mushil,” Zhongguo Minzu Yiyao Zazhi, vol. 6, pp. 30–32, 2000.
View at: Google Scholar
A. Yusup, H. Upur, and A. Abuduaini, “ESR studies on the antioxidant effects of Munziq and Mushil of Abnormal Savda,” Zhong Yao Xin Yao Yu Lin Chuang Yao Li, vol. 12, pp. 420–422, 2001.
View at: Google Scholar
A. Yusup, H. Upur, A. Umar, and N. Moore, “Protective effects of Munziq and Mushil of Abnormal Savda to mitochondrial oxidative damage,” Fundamental and Clinical Pharmacology, vol. 18, no. 4, pp. 471–476, 2004.
View at: Publisher Site | Google Scholar
“Criteria of Materia Medica, Fascicule of Uighur Medicine,” Ministry of Health, People’s Republic of China. Science-Technology and Sanitary Press, Urumqi, Xinjiang, China, 1999.
View at: Google Scholar
H. Upur and A. Yusup, Theory of Hilit and Mizaj on Uighur Medicine and Modern Research on it, Science and Technology Press, Urumqi, China, 2003.
E. E. Creppy, P. Chiarappa, I. Baudrimont, P. Borracci, S. Moukha, and M. R. Carratù, “Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?” Toxicology, vol. 201, no. 1-3, pp. 115–123, 2004.
View at: Publisher Site | Google Scholar
N. M. Bradford, “A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye,” Analytical Biochemistry, vol. 72, pp. 248–254, 1976.
View at: Google Scholar
K. Abado-Becognee, T. A. Mobio, R. Ennamany et al., “Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein and DNA syntheses,” Archives of Toxicology, vol. 72, no. 4, pp. 233–236, 1998.
View at: Publisher Site | Google Scholar
S. N. El and S. Karakaya, “Radical scavenging and iron-chelating activities of some greens used as traditional dishes in Mediterranean diet,” International Journal of Food Sciences and Nutrition, vol. 55, no. 1, pp. 67–74, 2004.
View at: Publisher Site | Google Scholar
A. M. Disi, S. O. Tamimi, and G. M. Abuereish, “Effects of Anchusa strigosa root aqueous extract on gastric ethanol-induced ulcer in laboratory animals,” Journal of Ethnopharmacology, vol. 60, no. 3, pp. 189–198, 1998.
View at: Publisher Site | Google Scholar
E.-M. Choi and J.-K. Hwang, “Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare,” Fitoterapia, vol. 75, no. 6, pp. 557–565, 2004.
View at: Publisher Site | Google Scholar
S. Satyanarayana, K. Sushruta, G. S. Sarma, N. Srinivas, and G. V. Subba Raju, “Antioxidant activity of the aqueous extracts of spicy food additives–evaluation and comparison with ascorbic acid in vitro systems,” Journal of Herbal Pharmacotherapy, vol. 4, no. 2, pp. 1–10, 2004.
View at: Publisher Site | Google Scholar
G. Ruberto, M. T. Baratta, S. G. Deans, and H. J. D. Dorman, “Antioxidant and antimicrobial activity of Foeniculum vulgare and crithmum maritimum essential oils,” Planta Medica, vol. 66, no. 8, pp. 687–693, 2000.
View at: Publisher Site | Google Scholar
J. L. Guil-Guerrero, A. Díaz Delgado, M. C. Matallana González, and M. E. Torija Isasa, “Fatty acids and carotenes in some ber (Ziziphus jujuba Mill) varieties,” Plant Foods for Human Nutrition, vol. 59, no. 1, pp. 23–27, 2004.
View at: Publisher Site | Google Scholar
M. L. Sheela, M. K. Ramakrishna, and B. P. Salimath, “Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra,” International Immunopharmacology, vol. 6, pp. 494–498, 2006.
View at: Google Scholar
E. H. Jo, S. H. Kim, J. C. Ra, S. R. Kim, S. D. Cho, J. W. Jung et al., “Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells,” Cancer Letters, vol. 230, pp. 239–247, 2005.
View at: Google Scholar
S. E. Lee, H. J. Hwang, J.-S. Ha, H.-S. Jeong, and J. H. Kim, “Screening of medicinal plant extracts for antioxidant activity,” Life Sciences, vol. 73, no. 2, pp. 167–179, 2003.
View at: Publisher Site | Google Scholar
T. Fukai, K. Satoh, T. Nomura, and H. Sakagami, “Antinephritis and radical scavenging activity of prenylflavonoids,” Fitoterapia, vol. 74, no. 7-8, pp. 720–724, 2003.
View at: Publisher Site | Google Scholar
M. Kanazawa, Y. Satomi, Y. Mizutani et al., “Isoliquiritigenin inhibits the growth of prostate cancer,” European Urology, vol. 43, no. 5, pp. 580–586, 2003.
View at: Publisher Site | Google Scholar
S. Yamazaki, T. Morita, H. Endo et al., “Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma,” Cancer Letters, vol. 183, no. 1, pp. 23–30, 2002.
View at: Publisher Site | Google Scholar
M. M. Rafi, B. C. Vastano, N. Zhu et al., “Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines,” Journal of Agricultural and Food Chemistry, vol. 50, no. 4, pp. 677–684, 2002.
View at: Publisher Site | Google Scholar
T. K. Shetty, J. G. Satav, and C. K. K. Nair, “Protection of DNA and microsomal membranes in vitro by Glycyrrhiza Glabra L. against gamma irradiation,” Phytotherapy Research, vol. 16, no. 6, pp. 576–578, 2002.
View at: Publisher Site | Google Scholar
J. Ma, N.-Y. Fu, D.-B. Pang, W.-Y. Wu, and A.-L. Xu, “Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells,” Planta Medica, vol. 67, no. 8, pp. 754–757, 2001.
View at: Google Scholar
S. Tamir, M. Eizenberg, D. Somjen, S. Izrael, and J. Vaya, “Estrogen-like activity of glabrene and other constituents isolated from licorice root,” Journal of Steroid Biochemistry and Molecular Biology, vol. 78, pp. 291–298, 2001.
View at: Google Scholar
M. M. Rafi, R. T. Rosen, A. Vassil et al., “Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid,” Anticancer Research, vol. 20, no. 4, pp. 2653–2658, 2000.
View at: Google Scholar
X. G. Chen and R. Han, “Effect of glycyrrhetinic acid on DNA damage and unscheduled DNA synthesis induced by benzo (a) pyrene,” Yao Xue Xue Bao, vol. 29, no. 10, pp. 725–729, 1994.
View at: Google Scholar
A. Ferreira, C. Proenca, M. L. Serralheiro, and M. E. Araujo, “The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal,” Journal of Ethnopharmacology, vol. 108, pp. 31–37, 2006.
View at: Google Scholar
M. G. Evandri, L. Battinelli, C. Daniele, S. Mastrangelo, P. Bolle, and G. Mazzanti, “The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay,” Food and Chemical Toxicology, vol. 43, no. 9, pp. 1381–1387, 2005.
View at: Publisher Site | Google Scholar
A. Prashar, I. C. Locke, and C. S. Evans, “Cytotoxicity of lavender oil and its major components to human skin cells,” Cell Proliferation, vol. 37, no. 3, pp. 221–229, 2004.
View at: Publisher Site | Google Scholar
V. Hajhashemi, A. Ghannadi, and B. Sharif, “Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill,” Journal of Ethnopharmacology, vol. 89, no. 1, pp. 67–71, 2003.
View at: Publisher Site | Google Scholar
M. E. Büyükokuroǧlu, A. Gepdiremen, A. Hacimüftüoǧlu, and M. Oktay, “The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups,” Journal of Ethnopharmacology, vol. 84, no. 1, pp. 91–94, 2003.
View at: Publisher Site | Google Scholar
J. Hohmann, I. Zupkó, D. Rédei et al., “Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their constituents against enzyme- dependent and enzyme-independent lipid peroxidation,” Planta Medica, vol. 65, no. 6, pp. 576–578, 1999.
View at: Publisher Site | Google Scholar
C. Proestos, N. Chorianopoulos, G. J. Nychas, and M. Komaitis, “RP-HPLC analysis of the phenolic compounds of plant extracts. Investigation of their antioxidant capacity and antimicrobial activity,” Journal of Agricultural and Food Chemistry, vol. 53, pp. 1190–1195, 2005.
View at: Google Scholar
T. K. Panovska, S. Kulevanova, and M. Stefova, “In vitro antioxidant activity of some Teucrium species (Lamiaceae),” Acta Pharmaceutica, vol. 55, no. 2, pp. 207–214, 2005.
View at: Google Scholar
D. Ivanova, D. Gerova, T. Chervenkov, and T. Yankova, “Polyphenols and antioxidant capacity of Bulgarian medicinal plants,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 145–150, 2005.
View at: Publisher Site | Google Scholar
A. C. de Sousa, D. S. Alviano, A. F. Blank, P. Barreto Alves, C. S. Alviano, and C. R. Gattass, “Melissa officinalis L. essential oil: antitumoral and antioxidant activities,” Journal of Pharmacy and Pharmacology, vol. 56, no. 5, pp. 677–681, 2004.
View at: Publisher Site | Google Scholar
M. Baba, R. Asano, I. Takigami et al., “Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis,” Biological and Pharmaceutical Bulletin, vol. 25, no. 2, pp. 247–250, 2002.
View at: Publisher Site | Google Scholar
T. Decker and M. L. Lohmann-Matthes, “A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity,” Journal of Immunological Methods, vol. 115, pp. 61–69, 1988.
View at: Google Scholar
A. R. Boobis, “Cell injury and death. Mechanisms of cell injury,” in Oxford Textbook of Pathology, J. D. McGee, P. G. Isaacson, and N. A. Wright, Eds., vol. 1, pp. 181–193, Barnes & Noble, Oxford, UK, 1992.
View at: Google Scholar
B. Halliwell and M. Whiteman, “Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?” British Journal of Pharmacology, vol. 142, pp. 231–255, 2004.
View at: Google Scholar
I. Valentin, M. Philippe, J.-C. Lhuguenot, and M.-C. Chagnon, “Uridine uptake inhibition as a cytotoxicity test for a human hepatoma cell line (HepG2 cells): comparison with the neutral red assay,” Toxicology, vol. 158, no. 3, pp. 127–139, 2001.
View at: Publisher Site | Google Scholar
A. Yusup, H. Upur, I. Baudrimont et al., “Cytotoxicity of Abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells,” Fundamental and Clinical Pharmacology, vol. 19, no. 4, pp. 465–472, 2005.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2011 Halmurat Upur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2659

Downloads

1160

Citations